Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Muscle Nerve. 2015 Aug 26;52(4):659–661. doi: 10.1002/mus.24766

Table 1.

Relative Risk of comorbidities in Myotonic Dystrophy

Co-morbidity Number
Observed
Number
Expected
P-value Relative Risk Mean Age at
Diagnosis of
Comorbidity1
(years) (SD;
range)
Cardiac Conduction Disorder 8 0.13 2.154E-12 60.2 (29.9, 108.6) 39.6 (11.3; 18–48 years)
Obstructive Sleep Apnea 12 1.23 8.042E-9 9.8 (5.6, 15.8) 45.4 (13.4; 22–74)
Central Sleep Apnea * * 4.486E-4 66.1 (11.7, 208.1) *
Intellectual Disabilities * * 0.0212 9.0 (1.6, 28.4) *
Hypothyroidism 6 2.32 0.0309 2.6 (1.1, 5.1) 51.5 (21.8; 27–79)
Myotonic Cataract * * 8.927E-4 1119.7 (57.6, 5311.4) *
Any Cataract 19 3.05 7.203E-10 6.23 (4.08, 9.15) 41.3 (12.4; 20–59)
*

-- indicates that the exact number is below 5 and cannot be reported due to data confidentiality

1

Mean age at diagnosis refers to the age at which the ICD-9 code for the comorbidity is used in the medical record for those individuals with myotonic dystrophy.

Abbreviations: Myotonic Dystrophy (DM), Myotonic Dystrophy type-1 (DM1), Myotonic Dystrophy type-2 (DM2), Utah Population Database (UPDB), University of Utah Health Sciences Center (UUHSC)